NNNN
NNNN
NASDAQ · Biotechnology

Anbio Biotechnology Ltd

$15.25
-0.45 (-2.87%)
As of Jun 24, 9:58 PM ET ·
Financial Highlights (FY 2026)
Revenue
28.49M
Net Income
21.09M
Gross Margin
87.2%
Profit Margin
74.1%
Rev Growth
-28.4%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 87.2% 87.2% 30.8% 30.8%
Operating Margin 66.7% 60.0% -15.2% -16.7%
Profit Margin 74.1% 70.4% -19.2% -20.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 28.49M 39.79M 1.84B 1.79B
Gross Profit 24.86M 34.71M 567.81M 552.88M
Operating Income 19.00M 23.88M -280,071,476 -300,415,133
Net Income 21.09M 26.51M -354,337,532 -367,227,211
Gross Margin 87.2% 87.2% 30.8% 30.8%
Operating Margin 66.7% 60.0% -15.2% -16.7%
Profit Margin 74.1% 70.4% -19.2% -20.5%
Rev Growth -28.4% -28.4% +17.6% +11.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 886.33M 752.45M
Total Equity 1.73B 1.94B
D/E Ratio 0.51 0.39
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 19.01M 25.22M -454,323,212 -381,836,603
Free Cash Flow -249,462,362 -276,575,086